CMS Enters the Octagon, Names 10 Drugs for Price Negotiation

This episode is brought to you by Semafor Healthcare.

Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.

Health Affairs' Rob Lott and Chris Fleming discuss Biden administration's announcement regarding the first 10 drugs selected for Medicare price negotiation.

Listen to the Research and Justice For All trailer.

Related Link:

• Biden-Harris Administration Announces First Ten Drugs Selected for Medicare Price Negotiation
• A Deep Dive Into Takings Clause Challenges to the Medicare Drug Price Negotiation Program (Health Affairs Forefront)
• Medicare Drug Price Negotiations: A Principles-Based Guide for CMS (Health Affairs Forefront)

Subscribe to Semafor Healthcare for free.